220 related articles for article (PubMed ID: 12878956)
1. Early activation of the alveolar macrophage is critical to the development of lung ischemia-reperfusion injury.
Naidu BV; Krishnadasan B; Farivar AS; Woolley SM; Thomas R; Van Rooijen N; Verrier ED; Mulligan MS
J Thorac Cardiovasc Surg; 2003 Jul; 126(1):200-7. PubMed ID: 12878956
[TBL] [Abstract][Full Text] [Related]
2. Early tumor necrosis factor-alpha release from the pulmonary macrophage in lung ischemia-reperfusion injury.
Naidu BV; Woolley SM; Farivar AS; Thomas R; Fraga CH; Goss CH; Mulligan MS
J Thorac Cardiovasc Surg; 2004 May; 127(5):1502-8. PubMed ID: 15116014
[TBL] [Abstract][Full Text] [Related]
3. Critical role of reactive nitrogen species in lung ischemia-reperfusion injury.
Naidu BV; Fraga C; Salzman AL; Szabo C; Verrier ED; Mulligan MS
J Heart Lung Transplant; 2003 Jul; 22(7):784-93. PubMed ID: 12873547
[TBL] [Abstract][Full Text] [Related]
4. Endotracheal calcineurin inhibition ameliorates injury in an experimental model of lung ischemia-reperfusion.
Woolley SM; Farivar AS; Naidu BV; Rosengart M; Thomas R; Fraga C; Mulligan MS
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):376-84. PubMed ID: 14762344
[TBL] [Abstract][Full Text] [Related]
5. Depletion of alveolar macrophages by clodronate-liposomes aggravates ischemia-reperfusion injury of the lung.
Nakamura T; Abu-Dahab R; Menger MD; Schäfer U; Vollmar B; Wada H; Lehr CM; Schäfers HJ
J Heart Lung Transplant; 2005 Jan; 24(1):38-45. PubMed ID: 15653377
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion.
Naidu BV; Woolley SM; Farivar AS; Thomas R; Fraga C; Mulligan MS
J Thorac Cardiovasc Surg; 2003 Aug; 126(2):482-9. PubMed ID: 12928648
[TBL] [Abstract][Full Text] [Related]
7. Decreased lung ischemia-reperfusion injury in rats after preoperative administration of cyclosporine and tacrolimus.
Krishnadasan B; Naidu B; Rosengart M; Farr AL; Barnes A; Verrier ED; Mulligan MS
J Thorac Cardiovasc Surg; 2002 Apr; 123(4):756-67. PubMed ID: 11986604
[TBL] [Abstract][Full Text] [Related]
8. The effect of anti-inflammatory properties of mycophenolate mofetil on the development of lung reperfusion injury.
Farivar AS; MacKinnon-Patterson B; Barnes AD; Mulligan MS
J Heart Lung Transplant; 2005 Dec; 24(12):2235-42. PubMed ID: 16364876
[TBL] [Abstract][Full Text] [Related]
9. Intratracheal poly (ADP) ribose synthetase inhibition ameliorates lung ischemia reperfusion injury.
Farivar AS; Woolley SM; Fraga CH; Thomas R; Salzman AL; Szabo C; Mulligan MS
Ann Thorac Surg; 2004 Jun; 77(6):1938-43. PubMed ID: 15172241
[TBL] [Abstract][Full Text] [Related]
10. The role of proinflammatory cytokines in lung ischemia-reperfusion injury.
Krishnadasan B; Naidu BV; Byrne K; Fraga C; Verrier ED; Mulligan MS
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):261-72. PubMed ID: 12579094
[TBL] [Abstract][Full Text] [Related]
11. Novel broad-spectrum chemokine inhibitor protects against lung ischemia-reperfusion injury.
Naidu BV; Farivar AS; Woolley SM; Grainger D; Verrier ED; Mulligan MS
J Heart Lung Transplant; 2004 Jan; 23(1):128-34. PubMed ID: 14734138
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 4 mediates lung ischemia-reperfusion injury.
Shimamoto A; Pohlman TH; Shomura S; Tarukawa T; Takao M; Shimpo H
Ann Thorac Surg; 2006 Dec; 82(6):2017-23. PubMed ID: 17126102
[TBL] [Abstract][Full Text] [Related]
13. Alpha chemokines regulate direct lung ischemia-reperfusion injury.
Farivar AS; Krishnadasan B; Naidu BV; Woolley SM; Verrier ED; Mulligan MS
J Heart Lung Transplant; 2004 May; 23(5):585-91. PubMed ID: 15135375
[TBL] [Abstract][Full Text] [Related]
14. Beta-chemokine function in experimental lung ischemia-reperfusion injury.
Krishnadasan B; Farivar AS; Naidu BV; Woolley SM; Byrne K; Fraga CH; Mulligan MS
Ann Thorac Surg; 2004 Mar; 77(3):1056-62. PubMed ID: 14992926
[TBL] [Abstract][Full Text] [Related]
15. Endogenous interleukin-4 and interleukin-10 regulate experimental lung ischemia reperfusion injury.
Farivar AS; Krishnadasan B; Naidu BV; Woolley SM; Verrier ED; Mulligan MS
Ann Thorac Surg; 2003 Jul; 76(1):253-9. PubMed ID: 12842552
[TBL] [Abstract][Full Text] [Related]
16. Essential role of alveolar macrophages in intrapulmonary activation of NF-kappaB.
Lentsch AB; Czermak BJ; Bless NM; Van Rooijen N; Ward PA
Am J Respir Cell Mol Biol; 1999 Apr; 20(4):692-8. PubMed ID: 10101001
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide pre-conditioning is protective in lung ischemia-reperfusion injury.
Merry HE; Wolf PS; Fitzsullivan E; Keech JC; Mulligan MS
J Heart Lung Transplant; 2010 Apr; 29(4):471-8. PubMed ID: 20044277
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-gamma ligand, on lung ischemia-reperfusion injury in rats.
Ito K; Shimada J; Kato D; Toda S; Takagi T; Naito Y; Yoshikawa T; Kitamura N
Eur J Cardiothorac Surg; 2004 Apr; 25(4):530-6. PubMed ID: 15037267
[TBL] [Abstract][Full Text] [Related]
19. Stress-activated protein kinase inhibition to ameliorate lung ischemia reperfusion injury.
Wolf PS; Merry HE; Farivar AS; McCourtie AS; Mulligan MS
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):656-65. PubMed ID: 18329489
[TBL] [Abstract][Full Text] [Related]
20. Depletion of alveolar macrophages decreases neutrophil chemotaxis to Pseudomonas airspace infections.
Hashimoto S; Pittet JF; Hong K; Folkesson H; Bagby G; Kobzik L; Frevert C; Watanabe K; Tsurufuji S; Wiener-Kronish J
Am J Physiol; 1996 May; 270(5 Pt 1):L819-28. PubMed ID: 8967517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
